Literature DB >> 3067415

A short history of thalidomide embryopathy.

W Lenz1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3067415     DOI: 10.1002/tera.1420380303

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


× No keyword cloud information.
  60 in total

Review 1.  Multiple myeloma.

Authors:  S Vincent Rajkumar
Journal:  Curr Probl Cancer       Date:  2009 Jan-Feb       Impact factor: 3.187

Review 2.  Incarnation and animation: physical versus representational deficits of body integrity.

Authors:  Leonie Maria Hilti; Peter Brugger
Journal:  Exp Brain Res       Date:  2009-10-25       Impact factor: 1.972

3.  Considering the Embryopathogenesis of VACTERL Association.

Authors:  R E Stevenson; A G W Hunter
Journal:  Mol Syndromol       Date:  2013-02

Review 4.  What can we learn from the thalidomide experience: an ophthalmologic perspective.

Authors:  Marilyn T Miller; Kerstin K Strömland
Journal:  Curr Opin Ophthalmol       Date:  2011-09       Impact factor: 3.761

5.  Pharmacovigilance in India: Present Scenario and Future Challenges.

Authors:  V Kalaiselvan; Sushma Srivastava; Abhishank Singh; S K Gupta
Journal:  Drug Saf       Date:  2019-03       Impact factor: 5.606

Review 6.  Implementation of a Pregnancy Prevention Programme (PPP) with a Controlled Distribution System (CDS) for the Generic Teratogenic Phthalimides Thalidomide, Lenalidomide and Pomalidomide.

Authors:  Marion Mueller; David J Lewis
Journal:  Ther Innov Regul Sci       Date:  2021-07-30       Impact factor: 1.778

Review 7.  Management of thalidomide toxicity.

Authors:  Irene M Ghobrial; S Vincent Rajkumar
Journal:  J Support Oncol       Date:  2003 Sep-Oct

8.  Inhibition of tumor necrosis factor-alpha by thalidomide in magnesium deficiency.

Authors:  W B Weglicki; R E Stafford; B F Dickens; I T Mak; M M Cassidy; T M Phillips
Journal:  Mol Cell Biochem       Date:  1993-12-22       Impact factor: 3.396

Review 9.  Cereblon and its downstream substrates as molecular targets of immunomodulatory drugs.

Authors:  Takumi Ito; Hiroshi Handa
Journal:  Int J Hematol       Date:  2016-07-26       Impact factor: 2.490

Review 10.  Congenital aberrant tearing: a re-look.

Authors:  Marilyn T Miller; Kerstin Strömland; Liana Ventura
Journal:  Trans Am Ophthalmol Soc       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.